Abstract:The anticancer drug carboplatin [Pt(cbdca-O,O')(NH3)(2)] which contains the chelated dicarboxylate ligand cbdca, cyclobutane-1,1-dicarboxylate, may be activated in vivo by reaction with sulfur ligands. The reactions between the analogue [Pt(en)(Me-Mal-O,O')] 1 (en = ethane-1,2-diamine, Me-Mal = 2-methylmalonate) and the methionine derivatives N-acetyl-L-methionine (Ac-Met), glycyl-L-methionine (Gly-Met) and L-methionylglycine (Met-Gly) have been studied at pH 7 and 4, 310 K, using H-1 and two-dimensional [H-1, N-15] heteronuclear single quantum coherence NMR spectroscopy and HPLC. The ring-opened species [Pt(en)(Me-Mal-O)(L-S)] (L = Ac-Met, Gly-Met or Met-Gly) containing monodentate malonate and S-bound monodentate methionine ligands were predominant in solution after 2 h. The second-order rate constant for the ring-opening reaction of 1 with Ac-Met at pH 6.56 was determined to be (1.48 +/- 0.03) x 10(-1) s(-1) M(-1), and was similar for reactions with Gly-Met. Methylmalonate alpha-CH deuteriation rates were determined to be free Me-Met > ring-opened complex much greater than 1. Molecular-mechanics modelling suggested that hydrogen bonding between the free carboxylate group of monodentate Me-Mal and the co-ordinated amine groups, and between the two ring-opened ligands may contribute to the stability of the mixed-ligand adducts. However, in the case of Met-Gly, the ring-opening rate [(5.26 +/- 0.10) x 10(-2) s(-1) M(-1)] was nearly three times slower than that for the reaction of 1 with Ac-Met. In contrast, the ring-closure rate of [Pt(en)(Me-Mal-O)(Met-Gly-S)] [k(1) = (1.37 +/- 0.03) x 10(-4) s(-1)] to give the S,N-chelated adduct was faster than that of [Pt(en)(Me-Mal-O)(Ac-Met-S)](-) 2 [(2.27 +/- 0.04) x 10(-5) s(-1)]. The S,N-chelated adducts [Pt(en)(Ac-MetH_(1)-S,N)] 3, [Pt(en)(Gly-MetH_(1)-S,N)](+) and [Pt(en)(Met-GlyH_(1)-S,N)](+) became the predominant products of the reactions after about 24 h. Ring-opened adducts of chelated dicarboxylate platinum anticancer complexes with methionine derivatives could play a significant role in their mechanism of action.

Fast Displacement of S,N-chelated L-Methionine in Platinum(ii) Complexes by Biological Thiols

Novel polynuclear platinum adducts detected during the reactions of [Pt(Met-S,N)Cl2] with γ-glutathione and l-cysteine

Delivery of Platinum (II) Drugs with Bulky Ligands in Trans-Geometry for Overcoming Cisplatin Drug Resistance.

Disulfide Bond Cleavage Induced by a Platinum(II) Methionine Complex

From Preassociation to Chelation: A Survey of Cisplatin Interaction with Methionine at Molecular Level by IR Ion Spectroscopy and Computations

Interactions of Platinum(ii) Complexes with Sulfur‐containing Peptides Studied by Electrospray Ionization Mass Spectrometry and Tandem Mass Spectrometry

ESMS and NMR investigations on the interaction of the anticancer drug cisplatin and chemopreventive agent selenomethionine †

Fast Cleavage of a Diselenide Induced by a Platinum(ii)-Methionine Complex and Its Biological Implications.

Mass Spectrometric Strategies to Improve the Identification of Pt(Ii)-Modification Sites on Peptides and Proteins

Reactivity of platinum-based antitumor drugs towards a Met- and His-rich 20mer peptide corresponding to the N-terminal domain of human copper transporter 1

Synthesis and Biological Activity of Binuclear Platinum Complexes Containing Two Monofunctional Cis-[Pt(Nh3)(2)Cl](+) Units Bridged by 4,4 '-Dipyridyl Selenides or Sulfides

Reactions of Platinum II Complexes with Sulfur- and Nitrogen-Containing Biomolecules: Selective Intermolecular Migration of the Thioether-Bound Platinum II Complex to the N7 Nitrogen Atom of Guanosine-5’-Monophosphate

The reaction of a platinated methionine motif of CTR1 with cysteine and histidine is dependent upon the type of precursor platinum complex.

Chelate-ring-opened Adducts of [Pt(en)(me-Mal-o,o′)] (en = Ethane-1,2-diamine, Me-Mal = 2-Methylmalonate) with Methionine Derivatives: Relevance to the Biological Activity of Platinum Anticancer Agents

A Trisulfide Bond Containing Biodegradable Polymer Delivering Pt(IV) Prodrugs to Deplete Glutathione and Donate H 2 S to Boost Chemotherapy and Antitumor Immunity

Palladium and platinum dihalide complexes with l-methioninol

Kinetics and mechanism of the substitution reactions of [PtCl(bpma)]+, [PtCl(gly-met-S,N,N)] and their aqua analogues with l-methionine, glutathione and 5′-GMP

Application Of High Performance Capillary Electrophoresis Tandem Mass Spectrometry To The Investigation On The Stability Of Novel Anticancer Platinum Complex In Solution

NMR Studies on Reactivity of Dinuclear Platinum(Ⅳ) Complex Towards Guanosine-5'-Monophosphate and Glutathione

Reactivity of Bis(Silyl)Platinum(Ii) Complexes Toward Organic Isothiocyanates: Preparation and Structures of (Dithiocarbonimidato)- and (diphenylsilanedithiolato)platinum(ii) Complexes, Cis-[Pt(S2c=Nph)L-2] and Cis-[Pt(S2siph2)L-2] (L = Pme2ph, Pet3; L-L = Dppp)

Platination of A Gg Site on Single-Stranded and Double-Stranded Forms of A 14-Base Oligonucleotide with Diaqua Cisplatin Followed by Nmr and Hplc - Influence of the Platinum Ligands and Base Sequence on 5'-G Versus 3'-G Platination Selectivity